| scholarly article | Q13442814 |
| P2093 | author name string | O Götze | |
| B P Morgan | |||
| P Gasque | |||
| J W Neal | |||
| S K Singhrao | |||
| P2860 | cites work | C5a-induced expression of P-selectin in endothelial cells | Q24633672 |
| C5A anaphylatoxin and its seven transmembrane-segment receptor | Q28243792 | ||
| Development of oligodendrocytes and Schwann cells studied with a monoclonal antibody against galactocerebroside | Q36292898 | ||
| Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor. | Q38317924 | ||
| Structure, function and cellular expression of complement anaphylatoxin receptors | Q40540064 | ||
| Expression of complement in the brain: role in health and disease | Q41203060 | ||
| Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. | Q41294733 | ||
| Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia | Q41321312 | ||
| Expression of functional receptors for human C5a anaphylatoxin (CD88) on the human hepatocellular carcinoma cell line HepG2. Stimulation of acute-phase protein-specific mRNA and protein synthesis by human C5a anaphylatoxin | Q41332829 | ||
| Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung | Q41369548 | ||
| Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules | Q41789499 | ||
| Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin | Q41974509 | ||
| C5a-mediated release of interleukin 6 by human monocytes | Q44090473 | ||
| Human microglial cells: Characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV-1 infection | Q44613060 | ||
| C5a induction of human interleukin 1. Synergistic effect with endotoxin or interferon-gamma | Q45245301 | ||
| Anaphylatoxin C5a modulation of an alpha-adrenergic receptor system in the rat hypothalamus | Q48477130 | ||
| Pre-oligodendrocytes from adult human CNS | Q48497799 | ||
| Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain. | Q64983482 | ||
| Identification and characterization of the effector region within human C5a responsible for stimulation of IL-6 synthesis | Q68148419 | ||
| Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: translational signal provided by lipopolysaccharide or IL-1 itself | Q68545203 | ||
| Binding specificity and presynaptic action of anaphylatoxin C5a in rat brain | Q69693131 | ||
| Characterization of a receptor for C5a anaphylatoxin on human eosinophils | Q69939533 | ||
| Role of complement in the aetiology of Pick's disease? | Q71071908 | ||
| Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes | Q71829063 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| astrocyte | Q502961 | ||
| microglia | Q1622829 | ||
| P304 | page(s) | 31-41 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system | |
| P478 | volume | 150 |
| Q44241464 | Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease. |
| Q42020450 | Activation by C5a of endothelial cell caspase 8 and cFLIP. |
| Q52331711 | An Inflammation-Centric View of Neurological Disease: Beyond the Neuron. |
| Q37415851 | Attenuation of IgG immune complex-induced acute lung injury by silencing C5aR in lung epithelial cells |
| Q81009319 | Blockade of the C5a receptor fails to protect against experimental autoimmune encephalomyelitis in rats |
| Q40852487 | C5a alters blood-brain barrier integrity in a human in vitro model of systemic lupus erythematosus |
| Q35552398 | C5a/CD88 signaling alters blood-brain barrier integrity in lupus through nuclear factor-κB |
| Q91757101 | C5aR agonist enhances phagocytosis of fibrillar and non-fibrillar Aβ amyloid and preserves memory in a mouse model of familial Alzheimer's disease |
| Q34361334 | CNS-specific expression of C3a and C5a exacerbate demyelination severity in the cuprizone model |
| Q21245239 | Characterization of early and terminal complement proteins associated with polymorphonuclear leukocytes in vitro and in vivo after spinal cord injury |
| Q36404031 | Chemotactic factors in cerebrospinal fluid during bacterial meningitis |
| Q55711128 | Complement Activation in Liver Transplantation: Role of Donor Macrosteatosis and Implications in Delayed Graft Function. |
| Q40468757 | Complement C5a is present in CSF of human newborns and is elevated in association with preterm birth. |
| Q36707253 | Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology |
| Q33722349 | Complement activation in multiple sclerosis plaques: an immunohistochemical analysis |
| Q43251890 | Complement factors C1q, C3 and C5 in brain and serum of mice with cerebral malaria |
| Q40673512 | Differential cytokine expression of human retinal pigment epithelial cells in response to stimulation by C5a. |
| Q42442943 | Elevation of basal intracellular calcium as a central element in the activation of brain macrophages (microglia): suppression of receptor-evoked calcium signaling and control of release function. |
| Q93186105 | Emerging Roles of Complement in Psychiatric Disorders |
| Q98735533 | Essential Role of Complement in Pregnancy: From Implantation to Parturition and Beyond |
| Q50559729 | Expression of C5a and its receptor following spinal cord ischemia reperfusion injury in the rat. |
| Q24669712 | Function, structure and therapeutic potential of complement C5a receptors |
| Q36446437 | Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization |
| Q90062401 | High Concentration of C5a-Induced Mitochondria-Dependent Apoptosis in Murine Kidney Endothelial Cells |
| Q41847449 | Identification of an astrocyte cell population from human brain that expresses perforin, a cytotoxic protein implicated in immune defense |
| Q41471218 | Immune consequences of penfluridol treatment associated with inhibition of glioblastoma tumor growth |
| Q43104143 | Immunity and inflammation in neurodegenerative diseases |
| Q34793122 | Increased C5a receptor expression in sepsis |
| Q28138617 | Inflammation and Alzheimer's disease |
| Q33985628 | Inhibition of C5a receptor alleviates experimental CNS lupus |
| Q37206724 | Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis |
| Q33769083 | Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease |
| Q27027097 | Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy |
| Q92358830 | Is there a link between genetic defects in the complement cascade and Porphyromonas gingivalis in Alzheimer's disease? |
| Q54967728 | Ischemia-reperfusion Injury in the Brain: Mechanisms and Potential Therapeutic Strategies. |
| Q38102608 | LXR agonists: new potential therapeutic drug for neurodegenerative diseases |
| Q36348374 | Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide |
| Q38137173 | Mast cells, glia and neuroinflammation: partners in crime? |
| Q42125266 | Mechanisms of brain signaling during sepsis |
| Q41760986 | Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's disease |
| Q39058653 | Modulation of retinal Müller cells by complement receptor C5aR. |
| Q38521270 | N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution |
| Q58612042 | Nanoparticulate matter exposure results in neuroinflammatory changes in the corpus callosum |
| Q37091310 | Neuroprotection in stroke by complement inhibition and immunoglobulin therapy |
| Q48013079 | PMX53 protects spinal cord from ischemia-reperfusion injury in rats in the short term |
| Q42712047 | Pharmacological Tools to Activate Microglia and their Possible use to Study Neural Network Patho-physiology. |
| Q35041753 | Pharmacological characterization of antagonists of the C5a receptor |
| Q38517519 | Potential new antiepileptogenic targets indicated by microarray analysis in a rat model for temporal lobe epilepsy. |
| Q35041610 | Response-selective C5a agonists: differential effects on neutropenia and hypotension in the rat. |
| Q34560179 | Roles of the complement system in human neurodegenerative disorders: pro-inflammatory and tissue remodeling activities. |
| Q42171559 | Sepsis-associated delirium: the pro and con of C5a blockade |
| Q64087538 | Significance of Complement System in Ischemic Stroke: A Comprehensive Review |
| Q43637662 | Species dependence for binding of small molecule agonist and antagonists to the C5a receptor on polymorphonuclear leukocytes |
| Q35829491 | Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis |
| Q55120072 | Systemic inhibition of the membrane attack complex impedes neuroinflammation in chronic relapsing experimental autoimmune encephalomyelitis. |
| Q73395775 | The C5a receptor is expressed in normal renal proximal tubular but not in normal pulmonary or hepatic epithelial cells |
| Q92888464 | The Novel C5aR Antagonist DF3016A Protects Neurons Against Ischemic Neuroinflammatory Injury |
| Q26744591 | The Role of ACTH and Corticosteroids for Sepsis and Septic Shock: An Update |
| Q34983578 | The role of the anaphylatoxins in health and disease |
| Q37599686 | The role of the complement system and the activation fragment C5a in the central nervous system |
| Q38918352 | Tumor necrosis-initiated complement activation stimulates proliferation of medulloblastoma cells |
| Q98177720 | Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics |
Search more.